Eriksson UG - Search Results

1

Pharmacokinetics of ximelagatran and relationship to clinical response in acute deep vein thrombosis.

Cullberg M, Eriksson UG, Wåhlander K, Eriksson H, Schulman S, Karlsson MO. Cullberg M, et al. Among authors: eriksson ug, eriksson h. Clin Pharmacol Ther. 2005 Apr;77(4):279-90. doi: 10.1016/j.clpt.2004.11.001. Clin Pharmacol Ther. 2005. PMID: 15903126 Clinical Trial.

2

Pharmacokinetics, pharmacodynamics and clinical effects of the oral direct thrombin inhibitor ximelagatran in acute treatment of patients with pulmonary embolism and deep vein thrombosis.

Wåhlander K, Lapidus L, Olsson CG, Thuresson A, Eriksson UG, Larson G, Eriksson H. Wåhlander K, et al. Among authors: eriksson ug, eriksson h. Thromb Res. 2002 Aug 15;107(3-4):93-9. doi: 10.1016/s0049-3848(02)00259-1. Thromb Res. 2002. PMID: 12431473 Clinical Trial.

3

Pharmacokinetics of melagatran and the effect on ex vivo coagulation time in orthopaedic surgery patients receiving subcutaneous melagatran and oral ximelagatran: a population model analysis.

Eriksson UG, Mandema JW, Karlsson MO, Frison L, Gisleskog PO, Wählby U, Hamrén B, Gustafsson D, Eriksson BI. Eriksson UG, et al. Among authors: eriksson bi. Clin Pharmacokinet. 2003;42(7):687-701. doi: 10.2165/00003088-200342070-00006. Clin Pharmacokinet. 2003. PMID: 12844328 Clinical Trial.

4

Pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, are not influenced by acetylsalicylic acid.

Fager G, Cullberg M, Eriksson-Lepkowska M, Frison L, Eriksson UG. Fager G, et al. Among authors: eriksson ug, eriksson lepkowska m. Eur J Clin Pharmacol. 2003 Aug;59(4):283-9. doi: 10.1007/s00228-003-0619-x. Epub 2003 Jul 4. Eur J Clin Pharmacol. 2003. PMID: 12845508 Clinical Trial.

5

No influence of mild-to-moderate hepatic impairment on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor.

Wåhlander K, Eriksson-Lepkowska M, Frison L, Fager G, Eriksson UG. Wåhlander K, et al. Among authors: eriksson ug, eriksson lepkowska m. Clin Pharmacokinet. 2003;42(8):755-64. doi: 10.2165/00003088-200342080-00004. Clin Pharmacokinet. 2003. PMID: 12846596 Clinical Trial.

6

Consistent pharmacokinetics of the oral direct thrombin inhibitor ximelagatran in patients with nonvalvular atrial fibrillation and in healthy subjects.

Wolzt M, Wollbratt M, Svensson M, Wåhlander K, Grind M, Eriksson UG. Wolzt M, et al. Among authors: eriksson ug. Eur J Clin Pharmacol. 2003 Oct;59(7):537-43. doi: 10.1007/s00228-003-0667-2. Epub 2003 Sep 4. Eur J Clin Pharmacol. 2003. PMID: 12955372 Clinical Trial.

7

Population pharmacokinetics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, in atrial fibrillation patients receiving long-term anticoagulation therapy.

Bååthe S, Hamrén B, Karlsson MO, Wollbratt M, Grind M, Eriksson UG. Bååthe S, et al. Among authors: eriksson ug. Clin Pharmacokinet. 2006;45(8):803-19. doi: 10.2165/00003088-200645080-00004. Clin Pharmacokinet. 2006. PMID: 16884319

8

Single-dose pharmacokinetics, pharmacodynamics and safety of AZD0837, a novel oral direct thrombin inhibitor, in young healthy male subjects.

Johansson S, Cullberg M, Eriksson UG, Elg M, Dunér K, Jensen E, Wollbratt M, Wåhlander K. Johansson S, et al. Among authors: eriksson ug. Int J Clin Pharmacol Ther. 2011 Apr;49(4):258-67. doi: 10.5414/CP201465. Int J Clin Pharmacol Ther. 2011. PMID: 21429440

9

Population modelling of the effect of inogatran, at thrombin inhibitor, on ex vivo coagulation time (APTT) in healthy subjects and patients with coronary artery disease.

Cullberg M, Eriksson UG, Larsson M, Karlsson MO. Cullberg M, et al. Among authors: eriksson ug. Br J Clin Pharmacol. 2001 Jan;51(1):71-9. doi: 10.1046/j.1365-2125.2001.01326.x. Br J Clin Pharmacol. 2001. PMID: 11167667 Free PMC article. Clinical Trial.

10

Antithrombotic effects of ximelagatran plus acetylsalicylic acid (ASA) and clopidogrel plus ASA in a human ex vivo arterial thrombosis model.

Wåhlander K, Eriksson-Lepkowska M, Nyström P, Eriksson UG, Sarich TC, Badimon JJ, Kalies I, Elg M, Bylock A. Wåhlander K, et al. Among authors: eriksson ug, eriksson lepkowska m. Thromb Haemost. 2006 Mar;95(3):447-53. doi: 10.1160/TH05-10-0664. Thromb Haemost. 2006. PMID: 16525572 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters